ATE41159T1 - Traeger mit einer immobilisierten biologischaktiven substanz, verfahren zur herstellung und seine verwendung. - Google Patents

Traeger mit einer immobilisierten biologischaktiven substanz, verfahren zur herstellung und seine verwendung.

Info

Publication number
ATE41159T1
ATE41159T1 AT85850271T AT85850271T ATE41159T1 AT E41159 T1 ATE41159 T1 AT E41159T1 AT 85850271 T AT85850271 T AT 85850271T AT 85850271 T AT85850271 T AT 85850271T AT E41159 T1 ATE41159 T1 AT E41159T1
Authority
AT
Austria
Prior art keywords
carrier
poly
active substance
activated
solution
Prior art date
Application number
AT85850271T
Other languages
English (en)
Inventor
Krister Holmberg
Holger Hyden
Original Assignee
Berol Kemi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berol Kemi Ab filed Critical Berol Kemi Ab
Application granted granted Critical
Publication of ATE41159T1 publication Critical patent/ATE41159T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT85850271T 1985-08-29 1985-08-29 Traeger mit einer immobilisierten biologischaktiven substanz, verfahren zur herstellung und seine verwendung. ATE41159T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP85850271A EP0212039B1 (de) 1985-08-29 1985-08-29 Träger mit einer immobilisierten biologisch-aktiven Substanz, Verfahren zur Herstellung und seine Verwendung

Publications (1)

Publication Number Publication Date
ATE41159T1 true ATE41159T1 (de) 1989-03-15

Family

ID=8194722

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85850271T ATE41159T1 (de) 1985-08-29 1985-08-29 Traeger mit einer immobilisierten biologischaktiven substanz, verfahren zur herstellung und seine verwendung.

Country Status (5)

Country Link
US (1) US4767701A (de)
EP (1) EP0212039B1 (de)
JP (1) JPS6266158A (de)
AT (1) ATE41159T1 (de)
DE (1) DE3568583D1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206178A (en) * 1986-11-19 1993-04-27 Genetic Systems Corporation Membrane affinity concentration immunoassay
JPH04507083A (ja) * 1989-05-19 1992-12-10 ヘム・リサーチ・インコーポレーテッド 規定された構造の短い治療用ｄｓＲＮＡ
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
GB2325233B (en) * 1997-05-16 2001-07-18 Norsk Hydro As Substrates having bound polysaccharides and bacterial nucleic acids
US6087342A (en) * 1998-05-15 2000-07-11 Fmc Biopolymer As Substrates having bound polysaccharides and bacterial nucleic acids
WO2001010468A2 (en) * 1999-08-09 2001-02-15 The General Hospital Corporation Drug-carrier complexes and methods of use thereof
EP2389289A4 (de) * 2009-01-23 2012-11-07 Univ Drexel Vorrichtung und verfahren für den nachweis von entzündungen anhand von quantenpunkten
CN112830495B (zh) * 2020-12-31 2023-12-29 苏州国纳思新材料科技有限公司 一种单分散胶体乳液的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56115727A (en) * 1980-02-19 1981-09-11 Kuraray Co Ltd Carrier for immobilizing physiologically active substance
JPS56141559A (en) * 1980-04-04 1981-11-05 Toray Ind Inc Reagent for immunological inspection
US4357142A (en) * 1980-07-18 1982-11-02 Akzona Incorporated Glass support coated with synthetic polymer for bioprocess
US4362697A (en) * 1981-04-20 1982-12-07 Miles Laboratories, Inc. Homogeneous specific binding assay test device having copolymer enhancing substance
JPS58209984A (ja) * 1982-05-28 1983-12-07 Japan Synthetic Rubber Co Ltd 粒子状重合体よりなる担体
JP2548112B2 (ja) * 1983-09-02 1996-10-30 シンジェン，インコーポレイテッド 担体およびオリゴヌクレオチドの合成

Also Published As

Publication number Publication date
US4767701A (en) 1988-08-30
EP0212039A1 (de) 1987-03-04
JPS6266158A (ja) 1987-03-25
DE3568583D1 (en) 1989-04-13
EP0212039B1 (de) 1989-03-08

Similar Documents

Publication Publication Date Title
ATE114689T1 (de) Verfahren zur behandlung von kollagen zur erleichterung seiner vernetzung und das so erhaltene kollagen.
DE69015424D1 (de) Verfahren zur Herstellung und Verwendung von Salzen von Polymeren der Maleinsäure mit verbesserter Biodegradabilität.
ATE148892T1 (de) Absorbierende polymere, verfahren zu deren herstellung und deren verwendung
ATE52857T1 (de) Lumineszenz immunoassay fuer haptene und hierfuer verwendbares chemilumineszent-markiertes haptenkonjugat sowie verfahren zur herstellung derselben.
DK236388A (da) Mikrogranulaert praeparat, der er anvendeligt til frigoerelse af biologisk aktive materialer i tarmregionerne hos dyr
DE3872560D1 (de) Eine antacide zusammensetzung.
NO884660L (no) Nedbrytbare kunststoffblandinger
DE3472263D1 (en) Protein/polysaccharide complexes
PL289710A1 (en) Method of treating surface of an absorptive resin and polymeric composition obtained thereby
ATE187646T1 (de) Verwendung von kupfer enthaltenden wirkstoffen zur beschleunigung der wundheilung
DE3851100D1 (de) Verfahren zur Herstellung eines Pflasters mit einer hydrophilen Acrylat-Klebstoff Schicht.
ATE41159T1 (de) Traeger mit einer immobilisierten biologischaktiven substanz, verfahren zur herstellung und seine verwendung.
DE3485198D1 (de) Verfahren zur herstellung optisch aktiver aryloxypropionsaeuren und deren derivate.
ATE44878T1 (de) Verfahren zur herstellung eines kollagen-vlieses.
CA2051426C (en) Process for cross-linking of collagen by diphenylphosphorylazide, the cross-linked collagen obtained thereby and collagen-based biomaterials thus cross-linked
DK35591A (da) Saarforbinding
ATE87323T1 (de) Granulierte zusammensetzung von polysacchariden, verfahren zu deren herstellung und verwendung.
DE3771123D1 (de) Verfahren zur herstellung von 3-methyl-1-vinyl-imidazoliumchloriden und ihre verwendung zur herstellung von polymerisaten.
ATE3974T1 (de) Verfahren zur herstellung von 4,4'-dinitrostilben-2,2'-disulfonsaeure und deren salzen und deren verwendung.
ATE191476T1 (de) Verfahren zur herstellung von indolderivaten
AT367754B (de) Verfahren zur herstellung von 1,4-benzodiazepin-2-on-derivaten und von deren salzen mit anorgani- schen saeuren
PL133551B1 (en) Method of making dressing materials of collagen
ATE15479T1 (de) Verfahren zur herstellung von formkoerpern zur keimfreihaltung von wasser und waesserigen loesungen.
ATA839877A (de) Verfahren zur herstellung von teilweise neuen 2 -aminomethyl-4,6-dihalogenphenoxyessigsaeure- alkylestern sowie deren additonssalzen mit saeuren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee